VDRL (RPR) FOR SYPHILIS

The Venereal Disease Research Laboratory (VDRL) test, also known as the rapid plasma reagin (RPR) test, detects antibodies against Treponema pallidum, the bacterium that causes syphilis, in the blood. This test is used to screen for and diagnose syphilis, guide treatment decisions, and monitor the effectiveness of therapy. A positive VDRL/RPR test indicates a current or past syphilis infection, prompting further evaluation and appropriate treatment. The test provides valuable information for managing syphilis, preventing complications, and ensuring timely intervention to reduce the spread of the infection.